Browse
FDA applications
Approved and filed applications connected to their products and owning companies.
29,787 results
| Application | Applicant | Application number |
|---|---|---|
| BLA 761216 | Emerge Bioscience Pte. Ltd. | BLA761216 |
| BLA 761219 | CELLTRION, Inc. | BLA761219 |
| BLA 761223 | GLAXOSMITHKLINE LLC | BLA761223 |
| BLA 761224 | AstraZeneca AB | BLA761224 |
| BLA 761225 | Hugel, Inc. | BLA761225 |
| BLA 761228 | Immunocore Limited | BLA761228 |
| BLA 761231 | Amneal Pharmaceuticals LLC | BLA761231 |
| BLA 761232 | BeOne Medicines USA, Inc. | BLA761232 |
| BLA 761234 | Bristol-Myers Squibb Company | BLA761234 |
| BLA 761235 | Genentech, Inc. | BLA761235 |
| BLA 761238 | TG Therapeutics, Inc. | BLA761238 |
| BLA 761240 | Coherus BioSciences, Inc. | BLA761240 |
| BLA 761244 | LEO Pharma A/S | BLA761244 |
| BLA 761248 | Eli Lilly and Company | BLA761248 |
| BLA 761255 | Fresenius Kabi USA, LLC | BLA761255 |
| BLA 761258 | Akeso Biopharma Co., Ltd. | BLA761258 |
| BLA 761261 | Genzyme Corporation | BLA761261 |
| BLA 761262 | AbbVie Inc. | BLA761262 |
| BLA 761263 | Genentech, Inc. | BLA761263 |
| BLA 761268 | CELLTRION, Inc. | BLA761268 |
| BLA 761269 | Eisai, Incorporated | BLA761269 |
| BLA 761270 | ASTRAZENECA AB | BLA761270 |
| BLA 761274 | Biocon Biologics Inc. | BLA761274 |
| BLA 761275 | Fresenius Kabi USA, LLC | BLA761275 |
| BLA 761278 | Chiesi Farmaceutici S.p.A. | BLA761278 |
| BLA 761279 | Eli Lilly and Company | BLA761279 |
| BLA 761285 | Amgen Inc. | BLA761285 |
| BLA 761286 | UCB, Inc. | BLA761286 |
| BLA 761289 | AstraZeneca AB | BLA761289 |
| BLA 761291 | Janssen Biotech, Inc. | BLA761291 |
| BLA 761297 | Sun Pharmaceutical Industries, Inc. | BLA761297 |
| BLA 761298 | Amgen Inc. | BLA761298 |
| BLA 761299 | Alvotech USA Inc. | BLA761299 |
| BLA 761304 | Argenx BV | BLA761304 |
| BLA 761306 | Eli Lilly and Company | BLA761306 |
| BLA 761309 | Genentech, Inc. | BLA761309 |
| BLA 761310 | ImmunoGen, Inc. | BLA761310 |
| BLA 761312 | Citius Oncology, Inc. | BLA761312 |
| BLA 761313 | HALOZYME THERAP | BLA761313 |
| BLA 761315 | Novo Nordisk Inc. | BLA761315 |
| BLA 761320 | Outlook Therapeutics, Inc. | BLA761320 |
| BLA 761322 | Sandoz Inc. | BLA761322 |
| BLA 761324 | Genmab US, Inc. | BLA761324 |
| BLA 761325 | Sanofi-Aventis U.S. LLC | BLA761325 |
| BLA 761326 | Novo Nordisk Inc. | BLA761326 |
| BLA 761328 | Sanofi Vaccines US Inc. | BLA761328 |
| BLA 761331 | Amgen Inc. | BLA761331 |
| BLA 761333 | Amgen Inc. | BLA761333 |
| BLA 761334 | Incyte Corporation | BLA761334 |
| BLA 761336 | Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc. | BLA761336 |